Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2012-05-08 Interim / Quarterly Rep…
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
10-Q Filing
Interim / Quarterly Report Q1 2012
2012-05-08 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 8, 2012, reporting the issuance of a press release regarding financial results for the quarter ended March 31, 2012. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is not deemed "filed" for certain regulatory purposes. The document itself is a current report announcing the earnings release, not the earnings release document itself. The length is 2601 characters, which is short and consistent with an announcement rather than a full report. Therefore, this is an Earnings Release announcement filed as a Form 8-K, which corresponds to the Earnings Release (ER) category.
2012-05-08 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The text indicates that the company issued a press release about the FDA lifting a clinical hold on a drug. The document includes the press release as an exhibit but does not contain financial statements or detailed financial data. The length is 2217 characters, which is relatively short and consistent with a current report announcing an event rather than a full financial report. There is no indication of earnings data, management discussion, or other report types. Therefore, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2012-05-07 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content describes a press release announcing the dosing of the first patient in a clinical study, which is a corporate event update. The document is short (2292 characters) and mainly references an attached press release (Exhibit 99.1). There are no financial statements or detailed financial data presented. This type of filing is best classified as a Regulatory Filing (RNS), as it is a general regulatory announcement and does not fit into more specific categories like earnings release or management report.
2012-04-17 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2012-04-10 English
8-K Filing
Call Transcript Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 15, 2012. It states that on March 13, 2012, Insmed Incorporated held a conference call to discuss financial results for the three and twelve months ended December 31, 2011. The document includes a transcript of that conference call as Exhibit 99.1. The text explicitly mentions the transcript of the conference call is attached and incorporated by reference. The content is primarily a transcript of a conference call discussing financial results, which fits the definition of a Call Transcript (CT). The document length is 4505 characters, which is relatively short but contains the transcript text, not just an announcement. Therefore, the classification is Call Transcript (CT) with high confidence.
2012-03-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.